Literature DB >> 26939555

Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.

M Tetikoglu1, H M Sagdik1, S Aktas1, F Ozcura1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26939555      PMCID: PMC4906445          DOI: 10.1038/eye.2016.28

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

Review 1.  Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches.

Authors:  Robert P Finger; Peter Charbel Issa; Markus S Ladewig; Christian Götting; Christina Szliska; Hendrik P N Scholl; Frank G Holz
Journal:  Surv Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 6.048

2.  Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.

Authors:  S Vaz-Pereira; L Collaço; G De Salvo; P van Zeller
Journal:  Eye (Lond)       Date:  2015-05-29       Impact factor: 3.775

3.  Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.

Authors:  Nicholas Papadopoulos; Joel Martin; Qin Ruan; Ashique Rafique; Michael P Rosconi; Ergang Shi; Erica A Pyles; George D Yancopoulos; Neil Stahl; Stanley J Wiegand
Journal:  Angiogenesis       Date:  2012-06       Impact factor: 9.596

4.  Angioid streaks, clinical course, complications, and current therapeutic management.

Authors:  Ilias Georgalas; Dimitris Papaconstantinou; Chrysanthi Koutsandrea; George Kalantzis; Dimitris Karagiannis; Gerasimos Georgopoulos; Ioannis Ladas
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

5.  Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks.

Authors:  Ebru Esen; Selcuk Sizmaz; Nihal Demircan
Journal:  Indian J Ophthalmol       Date:  2015-07       Impact factor: 1.848

  5 in total
  5 in total

1.  Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.

Authors:  S Vaz-Pereira; L Collaço; G De Salvo; P van Zeller
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775

2.  Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study.

Authors:  Martin Gliem; Johannes Birtel; Philipp Herrmann; Rolf Fimmers; Moritz Berger; Christoph Coch; Almut Wingen; Frank G Holz; Peter Charbel Issa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-20       Impact factor: 3.117

3.  Long-term follow-up of patients with choroidal neovascularization due to angioid streaks.

Authors:  Maria Guadalupe Martinez-Serrano; Abelardo Rodriguez-Reyes; Jose Luis Guerrero-Naranjo; Guillermo Salcedo-Villanueva; Jans Fromow-Guerra; Gerardo García-Aguirre; Virgilio Morales-Canton; Raul Velez-Montoya
Journal:  Clin Ophthalmol       Date:  2016-12-19

4.  Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks.

Authors:  Sónia Torres-Costa; João Bernardes; Sofia Sousa Mano; Joana Medeiros-Pinto; Ana Carolina Abreu; Maria João Furtado; Rufino Silva; Carlos Marques-Neves; Fernando Falcão-Reis; Ângela Carneiro; Luísa Colaço; Manuel Falcão
Journal:  J Ophthalmol       Date:  2022-07-09       Impact factor: 1.974

5.  Clinical characteristics and treatment outcomes of angioid streak associated choroidal neovascular membrane (AS-CNV): a Zambian case series.

Authors:  Kshitiz Kumar; Santosh Balasubramaniam; Amar Agarwal
Journal:  Pan Afr Med J       Date:  2020-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.